Education
About Us
Working with TipRanks
Follow Us
StemCell Institute (JP:7096)
:7096
RESEARCH TOOLSreports
7096 Stock Chart & Stats
Day’s Range― - ―
52-Week Range¥998.00 - ¥1,923.00
Previous CloseN/A
Volume70.10K
Average Volume (3M)50.22K
Market Cap
¥10.82B
Enterprise Value¥16.43B
Total Cash (Recent Filing)¥3.53B
Total Debt (Recent Filing)¥399.00M
Price to Earnings (P/E)27.7
Beta0.40
Next Earnings
Aug 06, 2025EPS EstimateN/A
Last Dividend Ex-Date
Sep 27, 2024Dividend YieldN/A
Share Statistics
EPS (TTM)4.49
Shares Outstanding10,246,600
10 Day Avg. Volume83,690
30 Day Avg. Volume50,220
Financial Highlights & Ratios
PEG Ratio1.47
Price to Book (P/B)5.29
Price to Sales (P/S)0.00
P/FCF Ratio-1.37K
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Options Prices
Currently, No data available
---
Ownership Overview
―
Insiders
0.05%
Mutual Funds
― Other Institutional Investors
99.95% Public Companies and
Individual Investors
7096 FAQ
What was StemCell Institute’s price range in the past 12 months?
StemCell Institute lowest stock price was ¥998.00 and its highest was ¥1923.00 in the past 12 months.
What is StemCell Institute’s market cap?
StemCell Institute’s market cap is ¥10.82B.
When is StemCell Institute’s upcoming earnings report date?
StemCell Institute’s upcoming earnings report date is Aug 06, 2025 which is in 45 days.
How were StemCell Institute’s earnings last quarter?
StemCell Institute released its earnings results on May 13, 2025. The company reported ¥4.49 earnings per share for the quarter, beating the consensus estimate of N/A by ¥4.49.
Is StemCell Institute overvalued?
According to Wall Street analysts StemCell Institute’s price is currently Overvalued.
Does StemCell Institute pay dividends?
StemCell Institute pays a Notavailable dividend of ¥25 which represents an annual dividend yield of N/A. See more information on StemCell Institute dividends here
What is StemCell Institute’s EPS estimate?
StemCell Institute’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does StemCell Institute have?
StemCell Institute has 10,246,600 shares outstanding.
What happened to StemCell Institute’s price movement after its last earnings report?
StemCell Institute reported an EPS of ¥4.49 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -1.093%.
Which hedge fund is a major shareholder of StemCell Institute?
Currently, no hedge funds are holding shares in JP:7096
Company Description
StemCell Institute
StemCell Institute Inc. engages in the stem cell banking business in Japan. The company is also involved in research and development of medical treatments using stem cells, as well as engages in banking of blood vessel cells businesses. StemCell Institute Inc. was incorporated in 1999 and is headquartered in Tokyo, Japan. StemCell Institute Inc. is a subsidiary of Trim Medical Holdings Inc.
Technical Analysis
StemRIM Inc.
―
CellSource Co., Ltd.
―
ReproCELL Inc.
―
Japan Tissue Engineering Co., Ltd.
―
CellSeed Inc.
―